Skip to main content
. Author manuscript; available in PMC: 2024 Sep 5.
Published in final edited form as: Eur J Med Chem. 2023 May 18;257:115501. doi: 10.1016/j.ejmech.2023.115501

Figure 1.

Figure 1.

Structures of HIV-1 protease inhibitors. (A) Darunavir (DRV), TMC-126, and the corresponding P1 phosphonate analog GS-8374. (B) DRV and GS-8374 bound to wild-type HIV-1 protease (PDB: 6DGX and 2I4W, respectively). The protease is depicted as a gray surface and a cartoon representation, with chain A in teal and chain B in magenta. (C) DRV analogs with variations at the P1′ and P2′ positions and the corresponding P1 phosphonate analogs analyzed in this study.